Related Experiment Videos
Lindane neurotoxicity in childhood
Anjum Singal1, Gurvinder P Thami
1Department of Dermatology and Venereology, Government Medical College Hospital, Chandigarh, India.
American Journal of Therapeutics
|June 15, 2006
Summary
Lindane, a treatment for scabies and lice, has potential neurotoxicity risks, particularly in children. Proper usage minimizes these risks, but safer alternatives now position it as a second-line therapy.
Area of Science:
- Dermatology
- Toxicology
- Pharmacology
Background:
- Lindane (gamma-benzene-hexachloride) has been a common scabicide and pediculicide for 50 years.
- Concerns exist regarding its neurotoxicity, especially in pediatric populations.
Purpose of the Study:
- To review the efficacy and safety profile of lindane.
- To assess the risks associated with lindane use in treating scabies and pediculosis.
Main Methods:
- Literature review of scientific publications on lindane's use and adverse effects.
- Analysis of reported neurotoxicity cases and risk factors.
Main Results:
- Lindane demonstrates reasonable efficacy for scabies and pediculosis.
- Neurotoxicity risk is minimal when lindane is used strictly according to recommendations.
- Safer alternatives are now available, leading to lindane's reduced usage.
Conclusions:
- Lindane remains an option for scabies and pediculosis but is now considered a second-line treatment.
- Adherence to proper usage guidelines is crucial to mitigate neurotoxicity risks.
- The availability of alternative therapies influences lindane's current therapeutic positioning.